Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
13.15
-0.35 (-2.59%)
At close: Sep 12, 2025, 4:00 PM EDT
13.35
+0.20 (1.52%)
After-hours: Sep 12, 2025, 6:46 PM EDT

Cadrenal Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
272610-
Market Cap Growth
214.97%168.05%--
Enterprise Value
21211-
Last Close Price
13.1514.4911.10-
PB Ratio
6.143.471.25-
P/TBV Ratio
6.263.471.25-
Debt / Equity Ratio
--0.00-0.11
Quick Ratio
3.333.7510.210.02
Current Ratio
3.563.7710.270.55
Return on Equity (ROE)
-340.31%-140.78%-780.59%-
Return on Assets (ROA)
-157.41%-73.49%-102.62%-
Return on Capital (ROIC)
-216.88%-90.41%-340.35%-
Earnings Yield
-52.41%-41.24%-86.73%-
FCF Yield
-43.38%-28.51%-36.67%-
Buyback Yield / Dilution
-54.78%-35.59%-70.99%-
Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q